The process by which the systemic and local actions of Growth Hormone (GH) and its primary mediator, Insulin-like Growth Factor-1 (IGF-1), stimulate cellular proliferation, collagen synthesis, and tissue remodeling to facilitate the restoration of damaged or aged skin structure. This endocrine pathway is crucial for maintaining dermal thickness, accelerating wound closure, and reversing some age-related cutaneous atrophy. It underscores the anabolic role of the somatotropic axis in integumentary health.
Origin
This term is a composite of “Growth Hormone” (a pituitary peptide hormone), “skin,” and “repair,” referring to the restoration of tissue integrity. Its origin is rooted in clinical endocrinology and wound healing research, where the therapeutic potential of GH and IGF-1 on tissue regeneration has been extensively studied. The concept is central to understanding the hormonal regulation of tissue anabolism.
Mechanism
Growth Hormone primarily acts indirectly by stimulating the hepatic and local production of IGF-1, which then binds to its receptors on dermal fibroblasts. IGF-1 signaling is a potent mitogen and stimulator of protein synthesis, driving fibroblast proliferation and significantly increasing the production of new collagen and other extracellular matrix components. This enhanced anabolic activity facilitates the deposition of new tissue required for efficient wound healing and the structural maintenance of the dermis.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.